Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia

May 2007

Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia.

But the ingredient in Invega is not really that new...it's the active metabolite of risperidone (Risperdal).

Expect Invega to work as well as risperidone, and have similar side effects such as restlessness or extrapyramidal symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote